New clinical staging proposal applied to a Fabry cardiomyopathy cohort

1 September 2024 (15:00 - 15:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Assistant Professor Elisabete Martins

Faculty of Medicine University of Porto, Porto (Portugal)

6 More presentations in this session

Presentation thumbnail

Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease

Doctor E. Monda (Naples, IT)

Abstract Slides Video

Presentation thumbnail

Artificial intelligence (AI)-enhanced electrocardiography: a machine-learning model for differential diagnosis between hypertrophic cardiomyopathy, cardiac amyloidosis and Anderson-Fabry disease

Doctor I. Ruotolo (Bologna, IT)

Abstract Slides Video

Presentation thumbnail

Development and validation of a smartphone based app to guide the differential diagnosis in patients with primary left ventricular hypertrophy: the Thick Heart App

Doctor N. Maurizi (Lausanne, CH)

Abstract Slides Video

Presentation thumbnail

Anderson-Fabry disease patients with anatomical heart hypertrophy express a higher degree of electrocardiographic hypertrophy compared to hypertrophic cardiomyopathy patients

Doctor F. Di Nicola (Bologna, IT)

Abstract Slides Video

Presentation thumbnail

Prognostic role of ECG patterns in Anderson Fabry disease.

Doctor S. Serratore (Catanzaro, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Anderson-Fabry disease: what is in store?

The Event

Event poster

ESC Congress 2024

1 September 2024 15:00 CET

You may be interested in

Congress Presentation

Cardiac involvement in Fabry disease

Congress Presentation

Evolution of cardiac damage staged with echocardiography in Fabry disease

Congress Presentation

Fabry disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources